Ultra-low dose rituximab controls disease activity for most rheumatoid arthritis patients in new study
by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study
Updated on: March 28,2024
17

Ultra-low dose rituximab controls disease activity for most rheumatoid arthritis patients in new study
by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study
Updated on:March 28,2024
17
